BioAlliance Pharma
Biotech Specialty Pharma
59, Boulevard du Gral Martial Valin, 4th Floor
Paris, 75015 France
phone: (33) 1 45 58 76 00
fax: (33) 1 45 58 08 81
Symbol BIO
Exchange EPA
Founded 0
Employees
www.bioalliancepharma.com
Research Sector Biotech Specialty Pharma
Summary Description
Therapeutics targeting cancer, HIV, and severe infections.
Management
Dominique Costantini, MD, Co-Founder, President and Chief Executive Officer; Gilles Avenard, MD, Co-Founder and Chief Operating Officer; Nicolas Fellmann , Chief Financial Officer; Florence Dupré, Vice President, Sales and Marketing; Laure Lagon, General Counsel
Ownership
Financials


* numbers in thousands

 
Keywords
biopharmaceutical, drug, resistance, therapeutics, cancer, hiv, infections, supportive care, radiotherapy, diabetics, elderly, ovarian, breast, lung, HIVAIDS

Comment | Printable Version | Apr. 28, 2007
If you work for BioAlliance Pharma and want to update this profile, click here


Description
BioAlliance Pharma is focused on drug resistance through development and commercialization of innovative therapeutics, targeting markets in cancer, HIV, severe infections and supportive care.


2008-11-20-318